期刊文献+

肝脏疾病应用D-二聚体、抗凝血酶Ⅲ、凝血因子Ⅷ、凝血因子Ⅸ检测对诊断患者病情的意义 被引量:3

Significance of D-two dimers,antithrombin Ⅲ,coagulation factor Ⅷ, coagulation factor Ⅸ detection in diagnosis of liver diseases
下载PDF
导出
摘要 目的:探讨肝脏疾病应用D-二聚体、抗凝血酶Ⅲ、凝血因子Ⅷ、凝血因子Ⅸ检测对患者病情诊断的意义。方法:收治肝脏疾病患者60例,选择健康体检者20例,分为肝硬化组、肝炎组、肝癌组、健康人群组,分别检测血浆D-二聚体、抗凝血酶Ⅲ、凝血因子Ⅷ、凝血因子Ⅸ。结果:与健康人群组相比,肝癌与肝硬化组的D-二聚体含量上升明显,3组肝脏疾病患者的凝血因子Ⅷ显著升高;肝癌组的凝血因子Ⅸ较健康人群组显著升高;肝炎组和肝硬化组的抗凝血酶Ⅲ较健康人群组活性显著降低。结论:对肝脏疾病行病情诊断时,应加强检测血浆中D-二聚体、抗凝血酶Ⅲ、凝血因子Ⅷ、凝血因子Ⅸ,以提高病情诊断准确性。 Objective:To investigate the significance of D-two dimers,antithrombinⅢ,coagulation factorⅧ,coagulation factorⅨdetection in the diagnosis of liver diseases.Methods:60patients with liver disease were selected,20healthy subjects were selected.They were divided into the cirrhosis group,the hepatitis group,the liver cancer group and the healthy population group.They were given D-two dimers,antithrombinⅢ,coagulation factorⅧ,coagulation factorⅨdetection.Results:Compared with healthy population,the contents of D-two dimers in the liver cancer group and the cirrhosis group were obviously increased,coagulation factorⅧof three liver disease groups was significantly increased.Compared with healthy population group,the coagulation factorⅨof the liver cancer group was significantly increased.Compared with healthy population group,the activity of antithrombinⅢof the cirrhosis group and the hepatitis group was markedly decreased.Conclusion:For diagnosis of liver disease,we should strengthen the plasma D-two dimers,antithrombinⅢ,coagulation factorⅧ,coagulation factorⅨdetection,in order to improve the diagnostic accuracy of the disease.
作者 李雪平 李雪玉 Li Xueping;Li Xueyu(The Second People's Hospital of Zunyi City 563000;Health Service Station of Suiyang Community,Huichuan District,Zunyi City 563000)
出处 《中国社区医师》 2017年第23期119-120,共2页 Chinese Community Doctors
关键词 D-二聚体 抗凝血酶Ⅲ 凝血因子Ⅷ 凝血因子Ⅸ 肝脏疾病 D-two dimers Antithrombin Ⅲ Coagulation factor Ⅷ Coagulation factor Ⅸ Liver diseases
  • 相关文献

参考文献5

二级参考文献34

  • 1赵振军 ,张丽杰 ,武湘云 ,孙桂兰 ,李如意 ,冯文莉 .血浆部分凝血因子在疾病中的变化及其意义[J].国外医学(临床生物化学与检验学分册),2005,26(4):224-226. 被引量:1
  • 2黄伏生,龚木英,韩秋珍,杜艳,周自刚.血小板图象分布及其临床意义的探讨[J].武汉医学杂志,1996,20(2):122-123. 被引量:9
  • 3[3]Georg J, Broze JR. Tissue factor pathway inhibitor. [ J ] Thronb Haemost, 1995,74 ;90.
  • 4[4]Esmon Ct ,Ding W,Yasuhiro K ,et al. The protein C pathway:New in sighs[ J]. Thronb Haemost, 1997,78 ;70.
  • 5[5]沈迪,凌柱三.临床出血病学[M].北京:北京科学技术文献出版社,1995.
  • 6Poon MC, Luke KH. Haemophilia care in China : achievements of a decade of World Federation of Hemophilia treatment centre twin- ning activities[J]. Haemophilia, 2008,14(5) :879-888.
  • 7Papagrigoriou E, McEwan PA, Walsh PN, et al. Crystal structure of the factor Ⅺ zymogen reveals a pathway for transactivation[ J]. Nat Struct Mol Biol, 2006,13(6) :557-558.
  • 8Keularts IM, Zivelin A, Seligsohn U, et al. The role of factor :Ⅺ in thrombin generation induced by low concentrations of tissue fac- tor[ J 3. Thromb Haemost, 2001,85 (6) : 1060-1065.
  • 9von dem Bome PA, Cox LM, Bouma BN. Factor Ⅺ enhances fi- brin generation and inhibits fibrinolysis in a coagulation model ini- tiated by surface-coated tissue factor[ J]. Blood Coagul Fibrinoly- sis, 2006,17(4) :251-257.
  • 10Gomez K, Bohon-Maggs P. Factor Ⅺ deficiency[ J]. Haemophili- a, 2008,14(6) :1183-1189.

共引文献25

同被引文献37

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部